Cargando…

Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome

BACKGROUND: The aim of this study to compare the diagnostic accuracy of the metabolic syndrome (MetS) with the FINDRISC score to screen for type 2 diabetes mellitus T2DM in an overweight/obese population. METHODS: Subjects 18 years or older visiting the obesity clinic of the Antwerp University Hospi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meijnikman, Abraham S., De Block, Christophe E. M., Verrijken, An, Mertens, Ilse, Van Gaal, Luc F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831861/ https://www.ncbi.nlm.nih.gov/pubmed/29507612 http://dx.doi.org/10.1186/s13098-018-0310-0

Ejemplares similares

Comparative Assessment of ADA, IDRS, and FINDRISC in Predicting Prediabetes and Diabetes Mellitus in South Indian Population
por: Doddamani, Parveen, et al.
Publicado: (2021)

Effectiveness of a type 2 diabetes prevention program combining FINDRISC scoring and telephone-based coaching in the French population of bakery/pastry employees
por: Böhme, Philip, et al.
Publicado: (2019)

Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population
por: Bernabe-Ortiz, Antonio, et al.
Publicado: (2018)

NAFLD in type 1 diabetes: overrated or underappreciated?
por: Mertens, Jonathan, et al.
Publicado: (2021)

Characteristic of FINDRISC Score and Association with Diabetes Development in 6-Year Follow-Up in PURE Poland Cohort Study
por: Zatońska, Katarzyna, et al.
Publicado: (2021)

ModAsian FINDRISC as a Screening Tool for People with Undiagnosed Type 2 Diabetes Mellitus in Vietnam: A Community-Based Cross-Sectional Study
por: Doan, Long, et al.
Publicado: (2023)

Impact of sex and age on the performance of FINDRISC: the HUNT Study in Norway
por: Jølle, Anne, et al.
Publicado: (2016)

Translation, cross-cultural adaptation and validation of the Finnish Diabetes Risk Score (FINDRISC) for use in Brazilian Portuguese: questionnaire validity study
por: Conceição, Adrianny Larissa Oliveira, et al.
Publicado: (2020)

FINDRISC in Latin America: a systematic review of diagnosis and prognosis models
por: Carrillo-Larco, Rodrigo M, et al.
Publicado: (2020)

Cardiometabolic importance of 1-h plasma glucose in obese subjects
por: Haverals, Lien, et al.
Publicado: (2019)

Glucose Intolerance and the Amount of Visceral Adipose Tissue Contribute to an Increase in Circulating Triglyceride Concentrations in Caucasian Obese Females
por: Berings, Margot, et al.
Publicado: (2012)

Does Future Diabetes Risk Impair Current Quality of Life? A Cross-Sectional Study of Health-Related Quality of Life in Relation to the Finnish Diabetes Risk Score (FINDRISC)
por: Väätäinen, Saku, et al.
Publicado: (2016)

Incidence and predisposing factors for the development of disturbed glucose metabolism and DIabetes mellitus AFter Intensive Care admission: the DIAFIC study
por: Van Ackerbroeck, Sofie, et al.
Publicado: (2015)

Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
por: Vonghia, Luisa, et al.
Publicado: (2015)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos
por: Varela-Vega, Yuline, et al.
Publicado: (2023)

Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico
por: García-Alcalá, Hector, et al.
Publicado: (2012)

Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study
por: Jølle, Anne, et al.
Publicado: (2019)

Incidence and predisposing factors for the development of disturbed glucose metabolism and diabetes mellitus after intensive care admission: the DIAFIC study
por: Ackerbroeck, S Van, et al.
Publicado: (2015)

The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome
por: Zenoaga-Barbăroșie, C, et al.
Publicado: (2023)

Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy
por: Costa, Bernardo, et al.
Publicado: (2013)

Prevalence of metabolic syndrome in type 2 diabetes mellitus patients
por: Nsiah, Kwabena, et al.
Publicado: (2015)

Magnesium in Type 2 Diabetes Mellitus, Obesity, and Metabolic Syndrome
por: Barbagallo, Mario, et al.
Publicado: (2022)

Impact of Metabolic Syndrome Factors on Testosterone and SHBG in Type 2 Diabetes Mellitus and Metabolic Syndrome
por: Mohammed, Mukhtar, et al.
Publicado: (2018)

Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study
por: Van Gaal, Luc, et al.
Publicado: (2019)

The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer
por: Sousa, André P., et al.
Publicado: (2022)

Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes
por: Mertens, Jonathan, et al.
Publicado: (2023)

Metabolic Syndrome in Patients With Diabetes Mellitus
por: Essafi, Mohammed Amine, et al.
Publicado: (2022)

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
por: Davies, Michael J, et al.
Publicado: (2017)

Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire
por: Winkler, Gábor, et al.
Publicado: (2013)

A Study of the Metabolic Pathways Affected by Gestational Diabetes Mellitus: Comparison with Type 2 Diabetes
por: Spanou, Loukia, et al.
Publicado: (2022)

Efficacy and safety of the glucagon-like peptide-1 receptor agonist lixisenatide versus the dipeptidyl peptidase-4 inhibitor sitagliptin in young (<50 years) obese patients with type 2 diabetes mellitus()
por: Van Gaal, Luc, et al.
Publicado: (2014)

A comparison of two insulin infusion protocols in the medical intensive care unit by continuous glucose monitoring
por: De Block, Christophe E. M., et al.
Publicado: (2016)

Association of leukocyte telomere length with metabolic syndrome in type 2 diabetes mellitus
por: Peng, Xuemin, et al.
Publicado: (2021)

Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome
por: Najafi, Ali, et al.
Publicado: (2021)

Comparison of Accuracy of Diabetes Risk Score and Components of the Metabolic Syndrome in Assessing Risk of Incident Type 2 Diabetes in Inter99 Cohort
por: Shafizadeh, Tracy B., et al.
Publicado: (2011)

Trajectory patterns of metabolic syndrome severity score and risk of type 2 diabetes
por: Amouzegar, Atieh, et al.
Publicado: (2023)

Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population
por: Jin, Shenyi, et al.
Publicado: (2022)

Copy number variant analysis and expression profiling of the olfactory receptor-rich 11q11 region in obesity predisposition
por: Diels, Sara, et al.
Publicado: (2020)

Association between diabetes mellitus with metabolic syndrome and diabetic microangiopathy
por: ZHANG, XIAOYAN, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4mqnntjuaufpe0ev5dq727fnk4